<--GAT-->
Clinical Topics

Adherence to New Medications Is Critical for Veterans With Diabetes

by U.S. Medicine

August 19, 2018

KNOXVILLE, TN—How important is adherence to oral medications in reducing complications for veterans with diabetes?

A new study published in Diabetic Medicine looked at the relationship of following drug regimens to macrovascular and microvascular complications, time to insulin therapy, revascularization, admissions and death among veterans with uncomplicated diabetes.1

The retrospective cohort study was led by researchers from the University of Tennessee School of Pharmacy and included input from VAMCs in Nashville and Memphis. The study team used the VA Corporate Data Warehouse to examine 159,032 veterans diagnosed with uncomplicated diabetes during 2002–2014 and starting oral anti-diabetes therapy for the first time.

Researchers identified and confirmed the first uncomplicated diabetes diagnosis by subsequent oral anti-diabetes therapy initiation. To calculate adherence, they used outpatient pharmacy records including the proportion of days covered over the first year of therapy. Health outcomes were observed up to five years beyond the first oral anti-diabetes dispensation and analyzed with adjustments for baseline demographic and clinical characteristics.

Results indicated that, during the first five years of oral anti-diabetes treatment, people initially non‐adherent to oral anti-diabetes therapy were more likely to experience myocardial infarction (hazard ratio 1.14, 95% CI 1.03-1.27) and ischemic stroke (hazard ratio 1.22, 95% CI 1.05-0.1.42), or to die (hazard ratio 1.21; 95% CI 1.15-1.28).

In fact, veterans with less than 20% adherence in the first year had particularly high hazards for ischemic stroke (hazard ratio 1.78, 95% CI 1.27-2.49) and all‐cause death (hazard ratio 1.33, 95% CI 1.17-151), study authors pointed out. Patients who were adherence, however, were more likely to be diagnosed with a microvascular complication or chronic kidney disease.

“People who are non‐adherent to treatment were more likely to experience detrimental health outcomes within the first five years of anti-diabetes therapy,” study authors concluded. “Adherence is paramount to disease management and this should be stressed from the time at which treatment is initiated.”

1. Gatwood JD, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, Kovesdy CP. Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: a 5-year survival analysis. Diabet Med. 2018 Jul 6. doi: 10.1111/dme.13775. [Epub ahead of print] PubMed PMID: 29978496.


Comments are closed here.


Related Articles

Metformin Halves All-Cause Mortality in Frail Older Veterans

Other Important VA Studies at the American Diabetes Association 79th Scientific Sessions MIAMI—The first-line drug of choice for Type 2 diabetes, metformin has long been known to effectively reduce blood glucose levels and substantially cut... View Article

HIV Patients Had Lower PC Incidence in VA Study

NEW YORK—Non-AIDS defining cancers are increasingly important contributors to health outcomes for aging persons with HIV (PWH), according to a recent conference presentation which also pointed out that, although prostate cancer is prevalent in aging... View Article


U.S. Medicine Recommends


More From diabetes

Diabetes

Metformin Halves All-Cause Mortality in Frail Older Veterans

Other Important VA Studies at the American Diabetes Association 79th Scientific Sessions MIAMI—The first-line drug of choice for Type 2 diabetes, metformin has long been known to effectively reduce blood glucose levels and substantially cut... View Article

Diabetes

Greatest VA Weight Gains in Women Veterans Without Diabetes

ATLANTA—How does a diagnosis of diabetes affect weight management among U.S. veterans? A study in the journal Obesity (Silver Spring) sought to assess weight trends and diabetes prevalence among U.S. veterans.1 Atlanta VAMC researchers and... View Article

Diabetes

Diabetes Patients Do Well in Military Healthcare-to-VA Transition

SAN DIEGO—When service members leave active duty and receive healthcare in a different setting, care for conditions such as diabetes can suffer. A study in Military Medicine pointed out that changes in healthcare have been... View Article

Diabetes

NPs, PAs Have as Good Diabetes Outcomes as Physicians

DURHAM, NC—So-called physician extenders do as good a job as physicians at the VA in helping to achieve good outcomes in diabetes patients, according to a new study. The report in Annals of Internal Medicine... View Article

Diabetes

Veterans on Standard Diabetes Care Face Dangers from Hypoglycemia Subhead: Post-hoc VADT Analysis Links Low Blood Sugar to CV Events

BALTIMORE, MD—A post-hoc analysis of the Veterans Affairs Diabetes Trial (VADT) once again shines a spotlight on the dangers of hypoglycemia in veterans treated for Type 2 diabetes. The study published in Diabetes Care found... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up